BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9596962)

  • 1. [Hypoglycemic effects of peroxovanadate complexes on glucose transportor of diabetic rats].
    Yuan M; Yu B; Liang Y
    Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):208-11. PubMed ID: 9596962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of peroxovanadate complexes on reducing glycemia in diabetic rats and translocation of glucose transporter.
    Yuan M; Yu B; Liang Y
    Chin Med J (Engl); 1997 Sep; 110(9):715-9. PubMed ID: 9642333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral vanadyl treatment on diabetes-induced alterations in the heart GLUT-4 transporter.
    Kopp SJ; Daar J; Paulson DJ; Romano FD; Laddaga R
    J Mol Cell Cardiol; 1997 Sep; 29(9):2355-62. PubMed ID: 9299359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin-diabetic rats.
    Cam MC; Brownsey RW; Rodrigues B; McNeill JH
    Metabolism; 2001 Jun; 50(6):674-80. PubMed ID: 11398144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term bioaccumulation of vanadium when ingested with a tea decoction in streptozotocin-induced diabetic rats.
    Edel AL; Kopilas M; Clark TA; Aguilar F; Ganguly PK; Heyliger CE; Pierce GN
    Metabolism; 2006 Feb; 55(2):263-70. PubMed ID: 16423636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral vanadate and Tiron in treatment of diabetes mellitus in rats: improvement of glucose homeostasis and negative side-effects.
    Domingo JL; Sanchez DJ; Gomez M; Llobet JM; Corbella J
    Vet Hum Toxicol; 1993 Dec; 35(6):495-500. PubMed ID: 8303815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediation of beta-endorphin by isoferulic acid to lower plasma glucose in streptozotocin-induced diabetic rats.
    Liu IM; Chen WC; Cheng JT
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1196-204. PubMed ID: 12975496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of peroxovanadate compound on phosphoenolpyruvate carboxykinase gene expression and lipid metabolism in diabetic rats.
    Wang Y; Yu B
    Drugs Exp Clin Res; 1997; 23(3-4):111-5. PubMed ID: 9403271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective control of blood glucose status and toxicity in streptozotocin-induced diabetic rats by orally administration of vanadate in an herbal decoction.
    Zhang L; Zhang Y; Xia Q; Zhao XM; Cai HX; Li DW; Yang XD; Wang K; Xia ZL
    Food Chem Toxicol; 2008 Sep; 46(9):2996-3002. PubMed ID: 18601969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats.
    Zhang XF; Tan BK
    Acta Pharmacol Sin; 2000 Dec; 21(12):1157-64. PubMed ID: 11603293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective control of glycemic status and toxicity in Zucker diabetic fatty rats with an orally administered vanadate compound.
    Clark TA; Edel AL; Heyliger CE; Pierce GN
    Can J Physiol Pharmacol; 2004 Oct; 82(10):888-94. PubMed ID: 15573149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin enhances beta-endorphin secretion to lower plasma glucose in streptozotocin-induced diabetic rats.
    Chi TC; Ho YJ; Chen WP; Chi TL; Lee SS; Cheng JT; Su MJ
    Life Sci; 2007 Apr; 80(20):1832-8. PubMed ID: 17397876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypoglycemic effects of sodium metavanadate in diabetic mice and its effect on glucose phosphorylation].
    Xu MZ; Zhang AZ; Li XR; Xu W; Shen LW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2003 May; 37(3):174-7. PubMed ID: 12880563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of peroxovanadate compound on phenylalanine hydroxylase gene expression.
    Wang YL; Yu B
    Biol Trace Elem Res; 2000 Jun; 74(3):237-44. PubMed ID: 11055810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium metavanadate affected control and streptozotocin-diabetic rat liver golgi complexes.
    DabroĊ› W; Goc A; Turyna B; Kordowiak AM
    Pol J Pathol; 2006; 57(2):91-7. PubMed ID: 17019971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of vanadium treatment on bone in diabetic and non-diabetic rats.
    Facchini DM; Yuen VG; Battell ML; McNeill JH; Grynpas MD
    Bone; 2006 Mar; 38(3):368-77. PubMed ID: 16256449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformation changes in brain calcineurin in diabetic rats with or without treatment with vanadyl sulfate.
    Li H; Wei Q
    IUBMB Life; 2001 Jun; 51(6):373-6. PubMed ID: 11758805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-enhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium(V) and its permeability and cytotoxicity.
    Xie MJ; Yang XD; Liu WP; Yan SP; Meng ZH
    J Inorg Biochem; 2010 Aug; 104(8):851-7. PubMed ID: 20434776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-diabetic effects and pharmacokinetic profiles of bis(maltolato)oxovanadium in non-diabetic and diabetic rats.
    Zhang SQ; Zhong XY; Chen GH; Lu WL; Zhang Q
    J Pharm Pharmacol; 2008 Jan; 60(1):99-105. PubMed ID: 18088510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
    Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
    J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.